Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J. G. De La Garza-Salazar"'
Autor:
Juan-Manuel, Hernandez-Martinez, Roberto, Sánchez-Reyes, J G, De la Garza-Salazar, Oscar, Arrieta
Publikováno v:
Advances in experimental medicine and biology. 1168
Omics technologies have revolutionised fundamental and medical research. Oncology is perhaps the field where these technologies have been most rapidly adopted and where they have had their biggest impact, dramatically transforming clinical practice g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::daa1048ea30db1dfd9c2458e08421e1a
https://pubmed.ncbi.nlm.nih.gov/31713165
https://pubmed.ncbi.nlm.nih.gov/31713165
Autor:
F J, Arenas-Huertero, R, Herrera-Goepfert, R, Delgado-Chavez, J W, Zinser-Sierra, J G, De la Garza-Salazar, A, Herrera-Gomez, E, Perez-Cardenas
Publikováno v:
Journal of experimentalclinical cancer research : CR. 18(3)
Secretion of gelatinases A (MMP-2) and B (MMP-9) from 21 tumoral explants of squamous cell carcinoma (SCC) and five samples of normal mucosa of the oral cavity is demonstrated here. The explants were cultured into fetal bovine serum- and phenol red-d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::221ec2f4c6214940dcb1428db9371b46
https://pubmed.ncbi.nlm.nih.gov/10606169
https://pubmed.ncbi.nlm.nih.gov/10606169
Autor:
J. Reyes-Contreras, Eduardo Tellez, P. Castillo, J. G. De La Garza-Salazar, Daniela Morales-Espinosa, T. Ceron-Lizarraga, Luis Manuel Martínez-Barrera, O. G. Arrieta Rodriguez, Diana Flores-Estrada, N. Hernandez Pedro
Publikováno v:
Journal of Clinical Oncology. 25:18029-18029
18029 Background: Erlotinib, a tyrosine kinase inhibitor, has improved survival and quality of life in patients with non-small cell lung cancer (NSCLC) after fist-line or second-line chemotherapy. Asian origin, adenocarcinoma histology, female gender
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5c9ef568f3beff3e440521180c3b209
https://doi.org/10.1200/jco.2007.25.18_suppl.18029
https://doi.org/10.1200/jco.2007.25.18_suppl.18029
Autor:
Héctor Martínez-Said, J. G. De La Garza-Salazar, José Luis Aguilar-Ponce, X. Kon-Jara, P. García-López
Publikováno v:
Journal of Clinical Oncology. 22:9051-9051
9051 Background: The two most active single agents for advanced soft-tissue sarcomas (SST) are doxorubicin and ifosfamide with objective regression rates of 15% to 30% by systemic administration. Recent studies have evaluated the role of isolated lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b73f0ab93855a949a962c306fd096ed4
https://doi.org/10.1200/jco.2004.22.90140.9051
https://doi.org/10.1200/jco.2004.22.90140.9051
Publikováno v:
Gaceta medica de Mexico. 122(7-8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5439e3072c86e22a9fb124029565df01
https://pubmed.ncbi.nlm.nih.gov/3596130
https://pubmed.ncbi.nlm.nih.gov/3596130
Autor:
G, García, A, Beltrán-Ortega, R, Díaz-Perches, J G, de la Garza-Salazar, J, Noriega-Limón, L, Jiménez-Zamudio
Publikováno v:
Gaceta medica de Mexico. 120(7-8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a27bd23d344e630c7122eaf9b5f4b5e
https://pubmed.ncbi.nlm.nih.gov/6526215
https://pubmed.ncbi.nlm.nih.gov/6526215
Publikováno v:
Gaceta medica de Mexico. 122(7-8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a93bdce738cdcb9b74c5b09904e0e243
https://pubmed.ncbi.nlm.nih.gov/3556950
https://pubmed.ncbi.nlm.nih.gov/3556950
Autor:
J G, de la Garza Salazar
Publikováno v:
Ginecologia y obstetricia de Mexico. 42(252)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b12235498b1a83101aa4a5a6ad599ede
https://pubmed.ncbi.nlm.nih.gov/401388
https://pubmed.ncbi.nlm.nih.gov/401388